Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical and clinical results reported for Myrexis oncolytic compounds

Nov. 25, 2011

Melphalan flufenamide evaluated in phase I/IIa study

Nov. 25, 2011

Aeterna Zentaris licenses anticancer agent to Hikma

Nov. 24, 2011

Amgen tests antibody-drug conjugate targeting EGFRvIII

Nov. 24, 2011

Updated results presented from ongoing first-in-patient trial of PF-04691502

Nov. 24, 2011

Celgene to discontinue study of treatment regimen for castration-resistant prostate cancer

Nov. 23, 2011

EMA committee recommends approval of new indication for Herceptin

Nov. 23, 2011

Swissmedic approves Celgene's Revlimid

Nov. 23, 2011

New steroidal lactones from M. crassissima disclosed by PharmaMar

Nov. 23, 2011

Bendamustine evaluated in anaplastic glioma

Nov. 23, 2011

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...